Skip to product information
1 of 1

Merck Animal Health

Covexin 8-Cattle and Sheep

Covexin 8-Cattle and Sheep

Regular price $12.50 USD
Regular price Sale price $12.50 USD
Sale Sold out
Size

For the vaccination of healthy cattle and sheep against diseases caused by Cl. chauvoei, septicum, novyi type B, haemolyticum, tetani and perfringens types C & D. Immunity may be provided against type B. 

Dosage: Cattle - 5 ml IM or subcut, repeat in 6 weeks; Sheep - 5 ml subcut at 10-12 weeks of age, followed by 2 ml in 6 weeks. Revaccinate annually. Cattle and sheep should be revaccinated for Cl. novyi and haemolyticum every 5-6 months. 21 day slaughter withdrawal.

Anaphylactoid reactions may occur. Antidote : Epinephrine.

Manufacturer and/or Label Information

MERCK ANIMAL HEALTH
Intervet Inc.
2 GIRALDA FARMS, MADISON, NJ, 07940
Customer Service: 800-521-5767
Order Desk: 800-648-2118
Technical Service (Companion Animal): 800-224-5318
Technical Service (Livestock): 800-211-3573
Fax: 973-937-5557
Website: www.merck-animal-health-usa.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.
COVEXIN® 8

Intervet/Merck Animal Health

Clostridium Chauvoei-Septicum-Haemolyticum-Novyi-Tetani-Perfringens Types C & D Bacterin-Toxoid

For Animal Use Only

INDICATIONS: For the vaccination of healthy cattle and sheep as an aid in the prevention of diseases caused by Clostridium chauvoei, C. septicum, C. novyi Type B, C. haemolyticum (known also as C. novyi Type D), C. tetani and C. perfringens Types C and D.

Immunity is also provided as an aid in the prevention of diseases caused by the beta and epsilon toxins of an additional organism, C. perfringens Type B. Although C. perfringens Type B is not a significant problem in North America (US), immunity is derived from a combination of Type C (beta) and Type D (epsilon) C. perfringens fractions.

ADMINISTRATION AND DOSAGE: Shake well. Using aseptic technique.

CATTLE DOSAGE: Inject 5 mL subcutaneously or intramuscularly, repeated in 6 weeks. Revaccinate annually with 5 mL prior to periods of extreme risk or parturition. For animals subject to re-exposure to C. novyi Types B or D (C. haemolyticum) repeat the dose every 5 to 6 months. For C. perfringens Types B, C and D, revaccinate two weeks prior to parturition, introduction to lush pastures or finishing programs. Calves vaccinated under 3 months of age should be revaccinated at weaning or 4 to 6 months of age.

SHEEP DOSAGE: Inject 5 mL subcutaneously followed by a 2 mL dose in 6 weeks. Revaccinate annually with 2 mL prior to periods of extreme risk or parturition. For animals subject to re-exposure to C. novyi Types B or D (C. haemolyticum) repeat the dose every 5 to 6 months. Vaccination should be scheduled so that pregnant ewes receive their second vaccination or annual booster 2 to 6 weeks before lambing commences in the flock. Lambs should be given their primary course beginning at 10 to 12 weeks of age.

PRECAUTION: This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy. This level of performance may be affected by conditions of use such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions. Local reactions may be observed following subcutaneous administration to cattle.

CAUTION: Store at 35°-45°F (2°-7°C). Protect from freezing. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.

Manufactured by SCHERING-PLOUGH ANIMAL HEALTH LIMITED, UPPER HUTT, NEW ZEALAND

Distributed by INTERVET, INC., OMAHA, NE 68103 U.S.A.

U.S. Veterinary Permit No. 311



Code



50 mL
Cattle-10 doses.
Sheep-10 primary/25 booster doses.

067697

128664

250 mL
Cattle-50 doses.
Sheep-50 primary/125 booster doses.

067696

133705

CPN: 1047033.3
COLORADO SERUM COMPANY4950 YORK STREET, P.O. BOX 16428, DENVER, CO, 80216-0428Telephone: 303-295-7527Order Desk: 800-525-2065Fax: 303-295-1923Website: www.colorado-serum.comEmail: colorado-serum@colorado-serum.comTHIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

TETANUS TOXOID-CONCENTRATED

Colorado Serum

Adjuvanted

GENERAL INFORMATION: This product has been shown to be effective for the vaccination of healthy horses, cattle, sheep, goats, and swine against tetanus. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity is unknown. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Safety in pregnant animals is unknown.

Tetanus Toxoid is prepared by detoxifying tetanus toxin in such a manner as to allow the antigenic properties to remain intact. Product is purified, concentrated and adjuvanted to provide a low dose effective immunizing agent.

Each serial is tested for purity, safety, and potency in accordance with USDA requirements.

Tetanus is caused by a neurotoxin produced by growth of Clostridium tetani, an anaerobic (lives without air) micro-organism, in necrotic tissue. Affected animals become stiff, have difficulty swallowing, and have an increased pulse rate. Breathing is labored. Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw.

Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw. Thus, the term “lockjaw” is often used. Legs and tail are often stiff with abdominal muscles contracted. Tetanus stricken animals may be unusually sensitive to light and heat. Temperature of the animal generally remains normal, elevating only shortly before death.

Protective antibody levels usually occur about two weeks after the second injection of the primary immunization series. In contrast, administration of Tetanus Antitoxin is recommended for immediate, emergency, passive treatment of exposed animals with unknown vaccination history or with signs of tetanus infection.

DIRECTIONS: Do not vaccinate within 21 days before slaughter. Store at 2-8° C. Do not freeze. Do not mix with other products. Shake well before use. Use entire contents when first opened.

PRECAUTIONS: A transitory local reaction may occur at injection site. Anaphylactoid reaction may occur following administration of products of this nature. If noted, administer adrenalin or equivalent. In case of human exposure, consult a physician.

DOSAGE & ADMINISTRATION: For primary immunization, two doses should be administered subcutaneously or intramuscularly approximately 30 days apart. Use intramuscularly for horses as local reactions are more likely to occur if injected subcutaneously.

Horses: 1 ml IM

Cattle: 1 ml SC or IM

Sheep, Goats, Swine: 0.5 ml SC or IM

Historically, annual single dose revaccination has been recommended. Contact veterinarian for advice.

OTHER INFORMATION: Contains thimerosal and formalin as preservatives. Tetanus Toxoid Concentrate is available in single dose size packaged 10 vials to the carton, and in 10 dose vials.

THE PEAK OF QUALITY SINCE 1923

VLN: 188 / PCN: 8601.00

COLORADO SERUM COMPANY, 4950 York Street, Denver, Colorado 80216

303-295-752

www.colorado-serum.com

Contact us for information on other Colorado Serum Company products. Fine Veterinary Products since 1923.

FOR VETERINARY USE ONLY

 

 

Order #

10 - 1 ml vials

10 - 1 dose vials

11411

10 ml

10 doses

11415

CPN: 1101033.3

Dimensions

Care information

View full details